E-LIB Suche - Ergebnisse für: Dilhuydy, Marie Sarah

1

PB1925: NAOS STUDY: FIRST INTERIM ANALYSIS OF ACALABRUTINIB..:

Quinquenel, Anne ; Dilhuydy, Marie Sarah ; Ysebaert, Loïc...
HemaSphere. 7 (2023) S3 - p. e8766709 , 2023

Link: https://doi.org/10.1097/..

2

First‐line therapy for chronic lymphocytic leukemia in pati..:

Meunier, Godelieve ; Ysebaert, Loic ; Nguyen‐Thi, Phi Linh...
Hematological Oncology. 35 (2016) 4 - p. 671-678 , 2016

Link: https://doi.org/10.1002/..

3

Final results on effectiveness and safety of Ibrutinib in p..:

Dartigeas, Caroline ; Quinquenel, Anne ; Ysebaert, Loïc...
Annals of Hematology. , 2024

Link: https://doi.org/10.1007/..

4

A fixed-duration immunochemotherapy approach in CLL: 5.5-ye..:

Michallet, Anne-Sophie ; Letestu, Rémi ; Le Garff-Tavernier, Magali...
Blood Advances. 7 (2023) 15 - p. 3936-3945 , 2023

Link: https://doi.org/10.1182/..

5

Real-world outcomes following venetoclax therapy in patient..:

Bouclet, Florian ; Calleja, Anne ; Dilhuydy, Marie-Sarah...
Annals of Hematology. 100 (2021) 4 - p. 987-993 , 2021

Link: https://doi.org/10.1007/..

6

High incidence rate of human herpesvirus 6 infection after ..:

Simon, Favre ; Mathieu, Sauvezie ; Stephane, Vigouroux...
Archives of Clinical Nephrology. , 2021

Link: https://doi.org/10.17352..

7

Final 5-year findings from the phase 3 HELIOS study of ibru..:

Fraser, Graeme A.M. ; Chanan-Khan, Asher ; Demirkan, Fatih...
Leukemia & Lymphoma. 61 (2020) 13 - p. 3188-3197 , 2020

Link: https://doi.org/10.1080/..

8

Long-Term Studies Assessing Outcomes of Ibrutinib Therapy i..:

Kipps, Thomas J. ; Fraser, Graeme ; Coutre, Steven E....
Clinical Lymphoma Myeloma and Leukemia. 19 (2019) 11 - p. 715-722.e6 , 2019

Link: https://doi.org/10.1016/..

9

Systemic Exposure of Rituximab Increased by Ibrutinib: Phar..:

Lavezzi, Silvia Maria ; de Jong, Jan ; Neyens, Martine...
Pharmaceutical Research. 36 (2019) 7 - p. , 2019

Link: https://doi.org/10.1007/..

10

Safety Analysis of Four Randomized Controlled Studies of Ib..:

O'Brien, Susan ; Hillmen, Peter ; Coutre, Steven...
Clinical Lymphoma Myeloma and Leukemia. 18 (2018) 10 - p. 648-657.e15 , 2018

Link: https://doi.org/10.1016/..

11

Atrial fibrillation in CLL patients treated with ibrutinib...:

Thompson, Philip A. ; Lévy, Vincent ; Tam, Constantine S....
British Journal of Haematology. 175 (2016) 3 - p. 462-466 , 2016

Link: https://doi.org/10.1111/..

12

Risk Factors for Steroid-Refractory Acute Graft-versus-Host..:

Calmettes, Claire ; Vigouroux, Stéphane ; Labopin, Myriam...
Biology of Blood and Marrow Transplantation. 21 (2015) 5 - p. 860-865 , 2015

Link: https://doi.org/10.1016/..

13

Potent Graft-versus-Leukemia Effect after Reduced-Intensity..:

Labouré, Gaëlle ; Dulucq, Stéphanie ; Labopin, Myriam...
Biology of Blood and Marrow Transplantation. 18 (2012) 12 - p. 1845-1850 , 2012

Link: https://doi.org/10.1016/..

14

Methotrexate Reduces the Incidence of Severe Acute Graft-ve..:

Vigouroux, Stéphane ; Tabrizi, Reza ; Melot, Cyril...
Biology of Blood and Marrow Transplantation. 17 (2011) 1 - p. 93-100 , 2011

Link: https://doi.org/10.1016/..

15

Front-line High-Dose Chemotherapy with Rituximab Showed Exc..:

Dilhuydy, Marie-Sarah ; Lamy, Thierry ; Foussard, Charles...
Biology of Blood and Marrow Transplantation. 16 (2010) 5 - p. 672-677 , 2010

Link: https://doi.org/10.1016/..